PRECIGEN, INC. 4

COO Rutul R. Shah exercised options and sold 33,772 shares of PRECIGEN, INC. common stock on August 3, 2026 under a 10b5-1 plan.

On August 3, 2026, PRECIGEN, INC. Chief Operating Officer Rutul R. Shah exercised stock options for 33,772 shares of common stock at an exercise price of $2.33 per share and immediately sold the same 33,772 shares at $6.50 per share under a pre-arranged Rule 10b5-1 trading plan. The option exercise (coded M) increased his direct holdings to 531,523 shares before the sale, and the subsequent sale (coded S) reduced his direct ownership to 497,751 shares. The transaction yielded an implied gross sale value of approximately $219,518 and an option exercise cost of about $78,686, with the options noted as fully vested. Following the transactions, Shah continued to hold a significant equity position in the company, valued at roughly $3.24 million based on the reported $6.50 sale price.

Filing Facts

CIK

1356090

Ticker

PGEN

Form

4

Source Type

fda

Accession

0000950103-26-011711

Alert Tier

6